Behavioral
Structured Lifestyle Intervention
Structured Lifestyle Intervention is a behavioral intervention with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
40%
Ph not_applicable
3
60%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(1)
Other(1)
Detailed Status
Not yet recruiting2
Recruiting1
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (40.0%)
N/A3 (60.0%)
Trials by Status
recruiting120%
not_yet_recruiting240%
unknown120%
completed120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingnot_applicable
Tirzepatide Impact Assessment Study
NCT07740291
not_yet_recruitingphase_4
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
NCT07715929
not_yet_recruitingphase_4
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
NCT07630454
completednot_applicable
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk
NCT03688126
unknownnot_applicable
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study
NCT05007353
Clinical Trials (5)
Showing 5 of 5 trials
NCT07740291Not Applicable
Tirzepatide Impact Assessment Study
NCT07715929Phase 4
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
NCT07630454Phase 4
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
NCT03688126Not Applicable
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk
NCT05007353Not Applicable
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study
All 5 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 5